These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31615774)

  • 1. Getting to the heart of the matter: detecting and managing cardiac complications in systemic sclerosis.
    Varga J; Lee DC
    Ann Rheum Dis; 2019 Nov; 78(11):1452-1453. PubMed ID: 31615774
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heart involvement in systemic sclerosis: analysis of four cases].
    Wielosz E; Borys O; Błaszczak P; Majdan M
    Ann Acad Med Stetin; 2012; 58(1):33-9; discussion 39. PubMed ID: 23547392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis.
    Guerra F; Stronati G; Fischietti C; Ferrarini A; Zuliani L; Pomponio G; Capucci A; Danieli MG; Gabrielli A
    Eur J Prev Cardiol; 2018 Oct; 25(15):1598-1606. PubMed ID: 29966435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of captopril on thallium 201 myocardial perfusion in systemic sclerosis.
    Kahan A; Devaux JY; Amor B; Menkès CJ; Weber S; Venot A; Strauch G
    Clin Pharmacol Ther; 1990 Apr; 47(4):483-9. PubMed ID: 2183960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myocardial tomoscintigraphy with 201Tl in the diagnosis of cardiac involvement in systemic scleroderma].
    Samoĭlenko LE; Bogdanov AP; Moiseev SV; Guseva NG; Pshenitsyn AI; Pasha SP; Sergienko VB
    Ter Arkh; 1996; 68(5):30-3. PubMed ID: 9082594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac complications of systemic sclerosis: recent progress in diagnosis.
    Boueiz A; Mathai SC; Hummers LK; Hassoun PM
    Curr Opin Rheumatol; 2010 Nov; 22(6):696-703. PubMed ID: 20657283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized Scleroderma, Systemic Sclerosis and Cardiovascular Risk: A Danish Nationwide Cohort Study.
    Hesselvig JH; Kofoed K; Wu JJ; Dreyer L; Gislason G; Ahlehoff O
    Acta Derm Venereol; 2018 Mar; 98(3):361-365. PubMed ID: 29136260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac involvement in scleroderma.
    Deswal A; Follansbee WP
    Rheum Dis Clin North Am; 1996 Nov; 22(4):841-60. PubMed ID: 8923599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiac complications in rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis].
    Gawrysiak W; Skrypnik K; Suliburska J; Skrypnik D; Bogdański P
    Przegl Lek; 2017; 74(4):179-82. PubMed ID: 29696959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of scleroderma heart by D-penicillamine.
    Muers M; Stokes W
    Br Heart J; 1976 Aug; 38(8):864-7. PubMed ID: 135572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart involvement in systemic sclerosis.
    Clements PJ; Furst DE
    Clin Dermatol; 1994; 12(2):267-75. PubMed ID: 8076265
    [No Abstract]   [Full Text] [Related]  

  • 12. The cardiovascular manifestations of systemic sclerosis (scleroderma).
    Follansbee WP
    Curr Probl Cardiol; 1986 May; 11(5):241-98. PubMed ID: 3487417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of iloprost (stable analog of PG12) in promoting neoangiogenesis in systemic sclerosis.
    Faggioli P; Giani L; Mazzone A
    Clin Exp Rheumatol; 2006; 24(2):220-1. PubMed ID: 16762173
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cardiovascular manifestations in progressive systemic sclerosis].
    Badui E; Robles E; Hernández C; García Rubí D; Mintz G
    Arch Inst Cardiol Mex; 1985; 55(3):263-8. PubMed ID: 2932080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of indium-111-antimyosin scintigraphy for diagnosis of myocardial damage in systemic sclerosis.
    Sarda L; Georges C; Assayag P; Lebtahi R; Faraggi M; Palazzo E; Le Guludec D
    J Nucl Med; 1997 Nov; 38(11):1759-61. PubMed ID: 9374348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular involvement in systemic sclerosis].
    Constans J; Skopinski S; Barcat D; Conri C
    Ann Med Interne (Paris); 2002 Jun; 153(4):242-9. PubMed ID: 12218890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic sclerosis: symptomatic treatment].
    Dziankowska-Bartkowiak B; Waszczykowska E; Skretkowicz K
    Pol Merkur Lekarski; 2003 Sep; 15(87):259-62. PubMed ID: 14679853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiopathy in systemic sclerosis].
    Valentini G; Maione S
    Recenti Prog Med; 1996 Nov; 87(11):557-63. PubMed ID: 9122540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scleroderma heart disease: an unusual cause of positive antimyosin cardiac imaging.
    Lekakis J; Mavrikakis M; Prassopoulos V; Gerali S; Sifakis N; Kostamis P; Stamatelopoulos S
    J Nucl Cardiol; 1999; 6(1 Pt 1):91-2. PubMed ID: 10070845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular manifestations in systemic scleroderma].
    Kane A; Kane A; Ba SA; Barry F; Dieng MT; Sarr M; Diousse P; Diop IB; Ly F; Hane L; Niang SO; Ndiaye NB; Ndiaye B; Diouf SM
    Presse Med; 1997 May; 26(17):796-800. PubMed ID: 9205481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.